Cardiovascular and Metabolic Research

At Hospital Universitario Virgen De Valme, this research area focuses on cardiovascular diseases and related metabolic disorders, including atherosclerotic cardiovascular disease, chronic heart failure, and dyslipidemia. The trials are mainly designed to test new treatment options and better ways to reduce major heart-related risks and complications.

  • Studying treatments for chronic heart failure with reduced ejection fraction and related outcomes
  • Evaluating approaches for atherosclerotic cardiovascular disease and prevention of major cardiovascular events
  • Assessing therapies aimed at improving LDL cholesterol control in dyslipidemia

This line of research supports better prevention and long-term management of common heart and lipid disorders in patients treated at the site.

Autoimmune and Inflammatory Disease Studies

A major focus at the Servicio de Medicina Interna is immune system diseases, especially systemic lupus erythematosus, idiopathic inflammatory myopathy, psoriatic arthritis, and axial spondyloarthritis. These trials are exploring new therapies to control inflammation, improve symptoms, and assess longer-term safety in chronic autoimmune conditions.

  • Research on systemic lupus erythematosus to improve disease control and symptom relief
  • Trials in idiopathic inflammatory myopathy and psoriatic arthritis evaluating safety and effectiveness
  • Studies in axial spondyloarthritis and related inflammatory disorders aimed at better symptom management

The site is contributing to the development of more targeted options for patients living with persistent autoimmune disease.

Oncology and Cancer Treatment Research

The site conducts extensive neoplasm research across several cancer types, including non-small cell lung cancer, small cell lung cancer, breast cancer, endometrial cancer, colorectal cancer, bladder cancer, and chronic lymphocytic leukemia. These studies are designed to test new anticancer strategies, compare treatment effectiveness, and improve survival outcomes.

  • Investigating new treatment options for lung cancer, including advanced and mutation-defined subtypes
  • Studying early breast cancer and recurrence prevention after initial treatment
  • Evaluating therapies for endometrial cancer, colorectal cancer, bladder cancer, and chronic lymphocytic leukemia

This cancer portfolio reflects a strong interest in both earlier-stage disease and advanced tumors, with a clear emphasis on improving patient outcomes.

Respiratory, Infectious, and Hospital-Based Studies

Research at Hospital Universitario Virgen De Valme also includes respiratory tract diseases and virus diseases, with studies in COVID-19 and lung cancer-related respiratory conditions. These trials often aim to understand treatment benefit in hospitalized patients, reduce disease progression, and improve care during acute illness.

  • Clinical studies in COVID-19 focused on hospitalized patients with moderate to severe disease
  • Trials in respiratory cancers assessing new treatment combinations and survival outcomes
  • Hospital-based research aimed at improving outcomes in acute infectious and respiratory conditions

This area highlights the site’s role in both pandemic-related research and complex respiratory disease management.

Digestive, Skin, and Other Specialized Clinical Research

The remaining studies cover a broad mix of digestive system diseases, skin and connective tissue diseases, and selected reproductive and urinary physiological phenomena. Key topics include ulcerative colitis, fertility-related research, and additional inflammatory conditions, with the goal of improving symptom control, treatment response, and patient quality of life.

  • Research in ulcerative colitis aimed at improving disease control in inflammatory bowel disease
  • Studies on male factor infertility exploring options to support conception
  • Additional work in skin and connective tissue and other less specific clinical areas

Together, these trials show a diverse internal medicine research program that extends beyond the major disease groups into other important clinical needs.